Cargando…
Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
Although the presence of nonalcoholic fatty liver disease (NAFLD) is known to be related to subclinical atherosclerosis, the relationship between the severity of NAFLD and subclinical atherosclerosis is not clear. This study aimed to clarify the factors related to subclinical arteriosclerosis, inclu...
Autores principales: | Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Kawano, Tadamichi, Koeda, Mai, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Kawamoto, Chiaki, Hatori, Tsutomu, Emoto, Naoya, Iio, Etsuko, Tanaka, Yasuhito, Iwakiri, Katsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853607/ https://www.ncbi.nlm.nih.gov/pubmed/31721770 http://dx.doi.org/10.1371/journal.pone.0224184 |
Ejemplares similares
-
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2021) -
Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study
por: Arai, Taeang, et al.
Publicado: (2022) -
Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial
por: Okubo, Tomomi, et al.
Publicado: (2021) -
Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data
por: Arai, Taeang, et al.
Publicado: (2021) -
How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis
por: Atsukawa, Masanori, et al.
Publicado: (2023)